New Delhi: Citing that the proposed study protocol of Esomeprazole Dual Release GastroResistant Tablets 80mg does not address all the aims of the phase IV clinical trial, the Subject Expert Committee ...

Additionally, low dose epinephrine 0.01 mg/kg IV, dexamethasone 0.2 mg/kg IV, chlorpheniramine 0.2 mg/kg SC, maropitant 1 mg/kg SC, esomeprazole 1 mg/kg IV, ampicillin/sulbactam 12.5 mg/kg IV was ...

The federal government will spend $20 million to expand the only local manufacturing facility of IV fluids. Production of the medicine is expected to jump from 60 million units a year to 80 ...